Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

539
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
539
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

865
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
865
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

36
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

828
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
828
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

90
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
90
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

516
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alumina foam-based electrolyte for thermal batteries: design and performance evaluation.

Scientific reports·2026
Same author

A foundation model of cancer genotype enables precise predictions of therapeutic response.

Cancer discovery·2026
Same author

Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19-09, CONPELAN Study.

Head & neck·2026
Same author

Artificial intelligence-powered H&E-based quantification of spatial tumor-infiltrating lymphocyte distribution identifies prognostic immune niches in colorectal cancer.

Cancer immunology, immunotherapy : CII·2026
Same author

Response to a letter to the editor on fracture risks in patients with arginine vasopressin deficiency: a nationwide matched cohort study (OSIN-D-26-00525).

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Lipiodol-Based Balloon-Occluded Transcatheter Arterial Chemoembolization Can Be a Curative Treatment Option for Hepatocellular Carcinoma.

Journal of vascular and interventional radiology : JVIR·2026

Related Experiment Video

Updated: Sep 27, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.6K

Outcome-Based Decision-Making Algorithm for Treating Patients with Primary Aldosteronism.

Jung Hee Kim1, Chang Ho Ahn2, Su Jin Kim3

  • 1Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

Endocrinology and Metabolism (Seoul, Korea)
|April 14, 2022
PubMed
Summary

This study developed a new algorithm to predict unilateral primary aldosteronism (PA) and surgical success. The algorithm aids clinical decisions, potentially improving patient outcomes and reducing unnecessary invasive procedures for PA management.

Keywords:
AdrenalectomyClinical decision rulesHyperaldosteronismPatient selectionTreatment outcome

More Related Videos

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

348
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Related Experiment Videos

Last Updated: Sep 27, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.6K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

348
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Surgical Decision Making

Background:

  • Primary aldosteronism (PA) increases cardiovascular and cerebrovascular risks.
  • Adrenal venous sampling (AVS) is the gold standard for PA subtyping but is invasive and technically difficult.
  • Some PA patients do not achieve clinical benefits from surgery, necessitating improved pre-operative decision-making.

Purpose of the Study:

  • To develop a predictive algorithm for unilateral aldosterone-producing adenoma.
  • To identify predictors of successful surgical outcomes in PA patients.
  • To enhance clinical decision-making regarding AVS and surgery for PA.

Main Methods:

  • Two studies (Study A: n=367, Study B: n=330) were conducted within the Korean Primary Aldosteronism Study.
  • Logistic regression and least absolute shrinkage and selection operator regression were used for model development and feature selection.
  • An independent validation dataset (n=53) was used to confirm the algorithm's performance.

Main Results:

  • A unilateral PA prediction model included low potassium (≤3.4 mEq/L), high aldosterone-to-renin ratio (≥150), high plasma aldosterone (≥30 ng/mL), and low BMI (<25 kg/m2) (AUC=0.819).
  • Predictors of successful surgery included female sex, hypertension duration (<5 years), low anti-hypertension medication use (<2.5 DD daily), and absence of coronary artery disease (Sensitivity=94.2%, Specificity=49.3%).
  • The developed algorithm demonstrated good predictive accuracy and was validated in an independent cohort.

Conclusions:

  • A novel, outcome-driven diagnostic algorithm for PA is proposed.
  • This algorithm integrates predictions for unilateral aldosterone excess and clinical surgical benefits.
  • It aims to optimize the management pathway for PA patients, guiding AVS and surgical interventions.